ELTX · XBRL financial data

Elicio Therapeutics financial statements, every fiscal year

The same tables from 5 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (ELTX's year ends in late December)

In thousands of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023†Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	28,312	2,301	—	—	—
Cost of revenue	433	0	—	—	—
Research and development	48,698	18,100	23,849	33,656	24,903
General and administrative	18,488	14,637	11,896	11,330	12,811
Operating income (loss)	(39,307)	(39,621)	(35,745)	(44,986)	(37,714)
Interest expense	—	3,597	1,059	455	1,133
Income tax expense (benefit)	0	11	0	0	0
Net income (loss)	(54,573)	(38,807)	(35,195)	(51,898)	(39,571)
Earnings per share, basic USD per share	(1.93)	(1.29)	(6.96)	(4.25)	(2.58)
Earnings per share, diluted USD per share	(1.93)	(1.29)	(6.96)	(4.25)	(2.58)
Weighted average shares, basic thousands of shares	28,245	30,041	5,056	12,203	15,313
Weighted average shares, diluted thousands of shares	28,245	30,041	5,056	12,203	15,313

† Share count changed about 1/3 in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal years (ELTX's year ends in late December)

In thousands of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023†Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	88,756	50,487	12,894	17,618	18,563
Prepaid and other current assets	1,685	943	2,732	1,897	748
Total current assets	91,247	51,430	16,348	20,693	19,311
Property and equipment, net	451	273	717	483	295
Right-of-use asset	3,986	152	6,563	5,706	4,782
Total assets	96,513	52,790	27,146	28,178	25,862
Accounts payable	4,710	2,720	4,369	1,038	672
Accrued liabilities	3,219	2,569	3,757	8,415	6,427
Total current liabilities	11,296	6,369	9,766	11,523	8,110
Long-term debt	0	—	—	20,034	9,407
Lease liability, non-current	3,475	2,481	6,007	5,105	4,094
Total liabilities	15,006	9,018	15,773	39,490	24,226
Accumulated deficit	(215,135)	(253,942)	(142,203)	(194,101)	(233,672)
Total stockholders' equity	81,507	43,772	11,373	(11,312)	1,636
Total liabilities and equity	96,513	52,790	27,146	28,178	25,862
Common shares outstanding (cover page) thousands of shares	29,958	30,114	10,235	15,954	18,396

† Share count changed about 1/3 in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal years (ELTX's year ends in late December)

In thousands of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023†Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(54,573)	(38,807)	(35,195)	(51,898)	(39,571)
Stock-based compensation	12,041	885	1,179	1,452	2,697
Net cash from operating activities	(52,643)	(38,390)	(32,694)	(37,068)	(36,952)
Purchases of property and equipment	382	0	66	87	16
Net cash from investing activities	(382)	0	(32)	(84)	(16)
Proceeds from issuing common stock	107,487	0	6,999	4,555	16,244
Net cash from financing activities	107,171	(60)	38,613	42,321	36,695
Net change in cash	54,149	(38,269)	5,887	5,191	(225)

† Share count changed about 1/3 in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

The peer list for this company is being put together from its industry's latest filings. Reload the page in a minute to see it.

Not investment advice. Not affiliated with the U.S. SEC.